Affiliations: [a] Division of Occupational Therapy and Physical Therapy, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
| [b]
Division of Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
| [c]
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA
| [d] Divisionof Rehabilitation Medicine, Cincinnati Children’s Hospital MedicalCenter, Cincinnati, OH, USA
Correspondence:
[*]
Corresponding author: Kelly Bonarrigo, Division of Occupational Therapy and Physical Therapy, Cincinnati Children’s Hospital Medical Center, MLC 4007, 3430 Burnet Ave., Cincinnati, OH 45229, USA. E-mail: [email protected].
Abstract: PURPOSE:This study aimed to explore stander use in individuals with Duchenne Muscular Dystrophy (DMD). METHODS:This mixed method research study employed a survey with categorical and open-ended questions related to stander use. Categorical responses were analyzed quantitatively. Qualitative analysis of open-ended responses was linked to the International Classification of Function. Qualitative and quantitative results were merged to derive meta-inferences. RESULTS:Of 147 respondents, 28.6% (n = 42) reported stander use. Equipment used included sit-to-stand stander (n = 27), power standing feature in a wheelchair (n = 13), and unspecified equipment (n = 2). Economic services were the most common barrier to stander obtainment. Age of loss of ambulation (LOA) and age of start of stander use were positively correlated (r = 0.61, p < 0.0001, n = 36), with 59.5% initiating stander use after LOA. Twenty-nine respondents reported standing less than the recommended dose of 60–90 minutes at least five days a week, with frequency directionally less than five days per week (p = 0.06) and time significantly less than 60–90 minutes (p = 0.002). Respondents’ total dose was significantly lower than the recommended 300 minutes (p = 0.02). Lack of time and presence of contractures contributed to decreased duration of use. CONCLUSION:This study provides a greater understanding of stander use among individuals with DMD and can assist with decision making about stander use prior to complications of disease progression to promote optimal health despite reported barriers.
